HIGHLIGHTS
- who: Martin Dolezel et al. from the Department of Oncology, Palacky University Medical School and Teaching Hospital have published the research: FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer, in the Journal: (JOURNAL)
- what: Despite amazing technological advances, precision in target coverage and surrounding tissue sparring, radiation oncology is still not considered a targeted treatment as long as the "one dose fits all" approach is used.
SUMMARY
In the 1950s, tumor hypoxia was first described by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.